ProCE Banner Activity

From CROI 2022: Future PrEP Options for Women

Clinical Thought
Read my take on promising new data from CROI 2022 on a vaginal ring containing tenofovir and long-acting cabotegravir as PrEP.

Released: March 01, 2022

Expiration: February 28, 2023

No longer available for credit.

Share

Faculty

Darrell H. S. Tan

Darrell H. S. Tan, MD, FRCPC, PhD

Clinician-Scientist
Division of Infectious Diseases
St. Michael's Hospital
Toronto, Canada

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Cepheid

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck & Co., Inc.

ViiV Healthcare

Faculty Disclosure

Primary Author

Darrell H. S. Tan, MD, FRCPC, PhD

Clinician-Scientist
Division of Infectious Diseases
St. Michael's Hospital
Toronto, Canada

Darrell H. S. Tan, MD, FRCPC, PhD, has disclosed that he has received funds for research support from AbbVie, Gilead Sciences, and GlaxoSmithKline.